Xaira Therapeutics raised a massive $1B in funding led by ARCH Venture Partners and Foresite Labs for AI drug discovery
Xaira Therapeutics raised a massive $1B in funding led by ARCH Venture Partners and Foresite Labs for AI drug discovery
04/25/24, 12:31 AM
Location
brisbaneMoney raised
$1 billion
Industry
therapeutics
machine learning
artificial intelligence
biotechnology
Investors
Sv Angel, Two Sigma Ventures, Menlo Ventures, Lightspeed Venture Partners, Lux Capital, Sequoia Capital, Nea, F Prime, Foresite Labs, Arch Venture Partners
Xaira Therapeutics, a startup specializing in AI drug discovery, has launched with a significant $1 billion funding round. The company aims to leverage recent AI breakthroughs to develop previously unattainable drugs.
Company Info
Location
brisbane, california, united states
Additional Info
Xaira Therapeutics is an AI drug discovery startup that aims to develop drugs using recent breakthroughs in AI technology. The company was incubated by ARCH Venture Partners and Foresite Labs, with additional funding from F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, and SV Angel.